Send me a link:

*Text messaging rates may apply.

 Dow Down 0.79% Nasdaq Down 1.01%

Oncothyreon Inc (ONTY)

-NasdaqGS
2.83 Down 0.06(2.08%) 10:12AM EDT - Nasdaq Real Time Price
Prev Close:2.89
Open:2.85
Bid:2.82 x 5000
Ask:2.83 x 800
1y Target Est:5.00
Beta:1.31
Next Earnings Date:N/A
Day's Range:2.81 - 2.89
52wk Range:1.58 - 4.08
Volume:49,026
Avg Vol (3m):577,023
Market Cap:200.22M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ONTY

Comparison

Symbol% ChgMkt Cap
ONTYDown 2.08%200.22M
GSKUp 0.43%116.93B
RHHBYDown 0.48%249.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:08-May-95

Analysts

Annual EPS Est (Dec-14) :-0.51
Quarterly EPS Est (Jun-14) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback